GSK Ireland IMPACT Awards offers €60,000 in funding to up to 10 community-based healthcare charities
You will be able to find all of our recent and archived news announcements. Our press releases are intended for business journalists.
Andy Moran, Cian O’Sullivan, Paul Geaney and Seán Óg Ó hAilpín launch 2018 #AllIrelandSmiles campaign
Mayo’s Andy Moran, Dublin’s Cian O’Sullivan, Kerry’s Paul Geaney and Cork’s Seán Óg Ó hAilpín are ambassadors for GSK’s #AllIrelandSmiles campaign for 2018.
GSK employees engage in variety of ‘serious’ and ‘fun’ activities at Kildare camp to help families coping with a seriously ill child
Programme offers four years on-the-job training, fully funded study opportunities and competitive salary
Irish charities rewarded for IMPACT they make in their local communities at GSK Ireland IMPACT Awards 2017
Awards programme recognises and rewards Ireland’s “unsung healthcare heroes” who make a real difference to health and wellbeing in their locality
Five winners each receive €10,000 while five runner-up charities receive €2,000 each
Healthcare heroes that are making an IMPACT – 2017 shortlist revealed for annual GSK Ireland IMPACT Awards
Up to five winning charities will receive €10,000 each, with five runner-up charities to receive €2,000 each
Awards designed to champion and reward the unsung heroes among small Irish healthcare charities
Building consumer insights into new product development: GSK Consumer Healthcare launches new European Consumer Sensory Lab
GSK Consumer Healthcare, one of the world's largest consumer healthcare companies, has launched a new Consumer Sensory Lab, the latest in a series of innovations to better understand the daily needs of consumers.
Dublin’s Cian O’Sullivan and Kerry’s Paul Geaney were on hand today to launch the #AllIrelandSmiles campaign for The Sensodyne and Corsodyl Team.
Novel approach to funding is part of GSK’s changes in how it works with and supports healthcare professionals
New facility is only second of its kind in Ireland and will reduce carbon emissions by 33%. This brings total investment in facility over past 24 months to €23.2m, underpinning GSK’s commitment to Dungarvan.